BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 27, 2015
View Archived Issues
biOasis Technologies and Brigham and Women's Hospital form neuro-oncology R&D agreement
Read More
Lilly divulges several analyses of phase III solanezumab trial data
Read More
Allogeneic mesenchymal precursor cells show promising results for the treatment of type 2 diabetes
Read More
ASK-1 inhibition protects mice from thrombosis
Read More
Lpath receives FDA clearance to start phase I trial of Lpathomab
Read More
Lupin to acquire Gavis
Read More
Researchers publish preclinical data that led to advancement of antimalarial agent DSM-265
Read More
Bausch + Lomb submits Vesneo NDA
Read More
Zalviso recommended for approval in Europe
Read More
EMA committee grants accelerated assessment to ixazomib for relapsed/refractory multiple myeloma
Read More
FDA approves Odomzo for locally advanced BCC
Read More
Biohaven files IND for BHV-0223 for treatment-resistant affective disorders
Read More
Algomedix presents TRPA1 antagonists
Read More
Bristol-Myers Squibb patents ROR-gamma modulators
Read More
Blend Therapeutics divulges platinum complexes for cancer
Read More
Jiangsu Hansoh Pharmaceutical Group introduces NS5B inhibitors
Read More
Rhizen Pharmaceuticals patents glutaminase inhibitors
Read More
FDA approves Technivie for genotype 4 chronic HCV infection
Read More
Genentech to advance crenezumab into phase III for prodromal to mild Alzheimer's disease
Read More
EMA committee recommends approval of Fexeric
Read More
FDA approves Praluent to treat high LDL cholesterol
Read More
EMA committee recommends approval of Intuniv for ADHD in children and adolescents
Read More
FDA approves Daklinza for genotype 3 chronic HCV infection
Read More
Genzyme to acquire vandetanib from AstraZeneca
Read More
EMA Committee hands down positive opinion for Revolade in severe aplastic anemia
Read More
FDA approves Kyprolis in combination use for relapsed multiple myeloma
Read More
Omeros's OMS-721 receives fast track designation for aHUS
Read More
European recommendation, U.S. priority review for Tafinlar and Mekinist combination
Read More